[1] Blaauw AA,van Loon AM,Schellekens JF,et al.Clinical evaluation of guidelines and two-test approach for Lyme disease.Rheumatology (Oxford),1999,38(11):1121-1126. [2] Walker DH.Tick-transmitted infectious diseases in the United States.Annu Rev Public Health,1998,19:237-269. [3] Huppertz HI,Bohme M,Standaert SM,et al.Incidence of Lyme borreliosis in the Wurzburg region of Germany.Eur J Clin Microbiol Infect Dis,1999,18(10):697-703. [4] 张哲夫,万康林,张金声.我国莱姆病的流行病学和病原学研究.中华流行病学杂志,1997,18(1):8-11. [5] 何素敏,杜卫东,张学军.莱姆病临床实验室诊断的研究现状.国外医学临床生物化学与检验学分册,2005,9(26):641-643. [6] Revel AT,Talaat AM,Norgard MV.DNA microarray analysis of differential gene expression in Borrelia burgdorferi,the Lyme disease spirochete.Proc Natl Acad Sci U S A,2002,99(3):1562-1567. [7] Pavlickova P,Jensen NM,Paul H,et al.Antibody detection in human serum using a versatile protein chip platform constructed by applying nanoscale self-assembled architectures on gold.J Proteome Res,2002,1(3):227-231. [8] Du W,Xu Z,Ma X,et al.Biochip as a potential platform of serological interferon alpha2b antibody assay.J Biotechnol,2003,106(1):87-100. |